StockClub

HALO

HALOHalozyme Therapeutics, Inc.$ --
Halozyme Therapeutics, Inc.

Halozyme Therapeutics, Inc.

HALO

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 03/31/2026FY2026 Q1
Revenue
377M USD
YoY +42.2%
Operating Income
185M USD
YoY +30.4%
Net Income
150M USD
YoY +27.1%
EPS
1.27$
YoY +32.3%

Revenue

$376.7M
FY2024 Q2$427.2M
$427.2M
Q2
FY2024 Q3$717.3M
$717.3M
Q3
FY2024 Q4$1B
$1B
Q4
FY2025 Q1$264.9M
$264.9M
Q1
FY2025 Q2$590.6M
$590.6M
Q2
FY2025 Q3$944.8M
$944.8M
Q3
FY2025 Q4$1.4B
$1.4B
Q4
FY2026 Q1$376.7M
$376.7M
Q1
Actual
+$111.8M (+42.2%)

Net Income

$150M
FY2024 Q2$170.1M
$170.1M
Q2
FY2024 Q3$307.1M
$307.1M
Q3
FY2024 Q4$444.1M
$444.1M
Q4
FY2025 Q1$118.1M
$118.1M
Q1
FY2025 Q2$283.3M
$283.3M
Q2
FY2025 Q3$458.5M
$458.5M
Q3
FY2025 Q4$316.9M
$316.9M
Q4
FY2026 Q1$150M
$150M
Q1
Actual
+$32M (+27.1%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020BEAT
Actual:$267.6M
Est:$265.2M
FY2020BEAT
$267.6M
FY2021BEAT
Actual:$443.3M
Est:$443.2M
FY2021BEAT
$443.3M
FY2022MISS
Actual:$660.1M
Est:$671.8M
FY2022MISS
$660.1M
FY2023MISS
Actual:$829.3M
Est:$873.3M
FY2023MISS
$829.3M
FY2024BEAT
Actual:$1B
Est:$1B
FY2024BEAT
$1B
FY2025BEAT
Actual:$1.4B
Est:$1.4B
FY2025BEAT
$1.4B

Analyst Estimates